National Peroxide Limited (BOM:544205)
India · Delayed Price · Currency is INR 602.80
+14.80 (2.52%)
At close: Oct 1, 2026
National Peroxide Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Cash & Equivalents | - | 188.02 | 129.27 | 86.08 |
Short-Term Investments | - | 64.72 | 1.18 | 80.27 |
Trading Asset Securities | - | 445.72 | 366.29 | 351.02 |
Cash & Short-Term Investments | 721.6 | 698.45 | 496.74 | 517.37 |
Cash Growth | 19.53% | 40.61% | -3.99% | - |
Accounts Receivable | - | 255.88 | 228.06 | 271.47 |
Other Receivables | - | 5.61 | 32.82 | 30.15 |
Receivables | - | 261.49 | 260.89 | 301.61 |
Inventory | - | 380.72 | 324.85 | 338.47 |
Prepaid Expenses | - | 5.94 | 3.7 | 23.55 |
Other Current Assets | - | 41.41 | 121.93 | 19.33 |
Total Current Assets | - | 1,388 | 1,208 | 1,200 |
Property, Plant & Equipment | - | 2,991 | 3,147 | 3,320 |
Long-Term Investments | - | 86.52 | 0.03 | - |
Other Intangible Assets | - | 3.82 | 5.02 | 0.31 |
Other Long-Term Assets | - | 118.13 | 56.66 | 72.51 |
Total Assets | - | 4,587 | 4,417 | 4,593 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Accounts Payable | - | 234.04 | 197.99 | 223.34 |
Accrued Expenses | - | 114.92 | 92.48 | 95.26 |
Current Portion of Long-Term Debt | - | 35.18 | 34.92 | 34.59 |
Current Portion of Leases | - | 5.7 | 3.44 | 2.4 |
Current Unearned Revenue | - | 102.48 | 29.28 | 43.12 |
Other Current Liabilities | - | 8.26 | 8.05 | 10.18 |
Total Current Liabilities | - | 500.57 | 366.16 | 408.87 |
Long-Term Debt | - | - | 35.18 | 70.06 |
Long-Term Leases | - | 86.27 | 86.92 | 90.36 |
Long-Term Unearned Revenue | - | 1.33 | - | - |
Pension & Post-Retirement Benefits | - | 3.88 | 6.19 | 6.34 |
Long-Term Deferred Tax Liabilities | - | 411.77 | 397.32 | 401.99 |
Other Long-Term Liabilities | - | 15.16 | 32.79 | 26 |
Total Liabilities | - | 1,019 | 924.56 | 1,004 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Common Stock | - | 57.47 | 57.47 | 57.47 |
Retained Earnings | - | 445.53 | 370.13 | 467.13 |
Comprehensive Income & Other | - | 3,065 | 3,065 | 3,065 |
Shareholders' Equity | 3,620 | 3,568 | 3,493 | 3,590 |
Total Liabilities & Equity | - | 4,587 | 4,417 | 4,593 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Total Debt | 127.14 | 127.14 | 160.46 | 197.4 |
Net Cash (Debt) | 594.46 | 571.31 | 336.28 | 319.98 |
Net Cash Growth | 24.32% | 69.89% | 5.10% | - |
Net Cash Per Share | 103.40 | 99.41 | 58.51 | 55.68 |
Filing Date Shares Outstanding | 5.75 | 5.75 | 5.75 | 5.75 |
Total Common Shares Outstanding | 5.75 | 5.75 | 5.75 | 5.75 |
Working Capital | - | 887.46 | 841.95 | 791.47 |
Book Value Per Share | 630.10 | 620.85 | 607.73 | 624.67 |
Tangible Book Value | 3,616 | 3,564 | 3,488 | 3,589 |
Tangible Book Value Per Share | 629.44 | 620.19 | 606.86 | 624.61 |
Buildings | - | 133.87 | 133.87 | 110.11 |
Machinery | - | 4,151 | 4,106 | 4,088 |
Construction In Progress | - | 26.72 | 28.65 | 112.63 |